Skin and skin structure infections (SSSIs) are common problems in both inpatients and outpatients. The vast majority of SSSIs are caused by gram-positive organisms that are normal flora on the skin of human beings. Staphylococci and streptococci cause majority of gram-positive infections \[[@B1]\]. A recent increase in staphylococcal infections caused by methicillin-resistant *Staphylococcus aureus* (MRSA) has resulted in a significant increase of cases of MRSA pneumonia in the health care setting, especially in the chronically ill population \[[@B2]\]. Vancomycin has been the cornerstone of treatment for MRSA infections. However, recently, vancomycin-resistant *S. aureus* and linezolid-resistant *Staphylococcus* strains have emerged \[[@B3][@B4][@B5]\]. These strains pose significant challenges to the clinical treatment of infections caused by these organisms. Tedizolid offers broad *in vitro* activity against gram-positive pathogens, including MRSA and strains resistant to vancomycin or linezolid, and has greater potency than other drugs of its class \[[@B6][@B7]\]. It was specifically designed to be active against linezolid-resistant *S. aureus*, including strains containing the multidrug-resistant *cfr* gene \[[@B8]\].

Tedizolid phosphate was recently approved by the U.S. Food and Drug Administration to treat patients with acute bacterial SSSI caused by *S. aureus*, various *Streptococcus* species, and *Enterococcus*. In addition, planned studies will investigate the potential role of tedizolid in the treatment of community-acquired bacterial pneumonia and hospital-acquired pneumonia (HAP) \[[@B9]\]. We published a previous report focusing on the activity of tedizolid against collections of clinical isolates in a single institution, but it was not characterized by infection type \[[@B10]\]. Therefore, the present study aimed to compare the activities of tedizolid to those of linezolid and other commonly used antimicrobial agents against gram-positive cocci recovered from patients with SSSIs and HAP in Korean hospitals.

Non-duplicated aerobic and anaerobic gram-positive isolates were collected from clinical specimens of 356 patients with SSSIs and 144 patients with HAP at eight hospitals in Seoul and Gyeonggi province, Korea from 2011 to 2014. SSSIs included impetigo, cellulitis, erysipelas, furuncles, abscesses, and infected burns \[[@B1][@B11]\]. HAP was defined as pneumonia that occurred 48 hr or more after admission.

Species were identified by using conventional methods or the Vitek 2 system (bioMérieux, Marcy l\'Etolile, France). Antimicrobial susceptibility was tested by using the CLSI agar dilution method \[[@B12][@B13]\]. Mueller-Hinton agar was used as a growth medium (Becton Dickinson, Cockeysville, MD, USA) for testing *Staphylococcus* spp. and *Enterococcus* spp.: Mueller-Hinton agar supplemented with 5% sheep blood for *Streptococcus* spp.; Brucella agar (Becton Dickinson) supplemented with 5 µg/mL hemin, 1 µg/mL vitamin K1; and 5% laked sheep blood for anaerobic bacteria. Tedizolid and linezolid (Dong-A ST, Seoul, Korea); erythromycin, tetracycline, oxacillin and penicillin G (Sigma Chemical, St. Louis, MO, USA); piperacillin and tazobactam (Yuhan, Seoul, Korea); clindamycin (Korea Upjohn, Seoul, Korea); levofloxacin (Daiichi Pharmaceutical, Tokyo, Japan); cefotetan (Daiichi Pharmaceutical); ampicillin and gentamicin (Chong Kun Dang, Seoul, Korea); cefoxitin and imipenem (Merck Sharp & Dohme, Rahway, NJ, USA); meropenem (Sumitomo, Tokyo, Japan); metronidazole (ChoongWae, Seoul, Korea); trimethoprim and sulfamethoxazole (Dong Wha, Seoul, Korea); vancomycin (Daewoong, Seoul, Korea); and teicoplanin (Sanofi Aventis, Bridgewater, NJ, USA) were used as antimicrobial powders. American type culture collection strains of *S. aureus* (ATCC29213), *E. faecalis* (ATCC 29212), *S. pneumoniae* (ATCC 49619), *Bacteroides fragilis* (ATCC 25285), and *B. thetaiotaomicron* (ATCC 29741) were used as reference strains. The non-meningeal breakpoints of penicillin G and cefotaxime were used for *S. pneumoniae*. This study used the breakpoints of tedizolid suggested by the US Food and Drug Administration \[[@B14]\].

All of the aerobic and anaerobic gram-positive isolates in patients with SSSIs were inhibited by ≤1 µg/mL tedizolid ([Table 1](#T1){ref-type="table"}). The most potent drugs against MRSA were tedizolid (minimum inhibitory concentration \[MIC\]~90~=0.5 µg/mL), linezolid (MIC~90~=2 µg/mL), and vancomycin (MIC~90~=2 µg/mL). The MIC range of tedizolid was 0.125 to 0.5 µg/mL for MRSA, while that of linezolid was 0.25 to 4 µg/mL. The MIC~90~s of tedizolid were 0.5 µg/mL for both MRSA and methicillin-susceptible *S. aureus* (MSSA) and ≤0.125 µg/mL for coagulase-negative staphylococci, which were 2- to 4-fold lower than those of linezolid. These MIC values were similar to those described in previous reports \[[@B10][@B15]\]. The MICs of tedizolid were 0.25 µg/mL for all three vancomycin-intermediate *S. aureus* isolates.

The MIC ranges of tedizolid were 0.25 to 0.5 µg/mL for *Enterococcus*, while those of linezolid were 0.5 to 2 µg/mL. Tedizolid inhibited all vancomycin-resistant *Enterococcus* at 0.5 µg/mL. When the meningeal breakpoint was applied, most of the pneumococcal isolates tested were not susceptible to penicillin G or cefotaxime. However, the MIC range of tedizolid was 0.25 to 1 µg/mL, and the MIC~90~ (0.5 µg/mL) was 4-fold lower than that of linezolid. Tedizolid inhibited all the isolates of viridans *Streptococcus* spp. and β-hemolytic streptococci such as *S. pyogenes* and *S. agalactiae* at 0.5 µg/mL.

Tedizolid had excellent activity against gram-positive anaerobes recovered from SSSIs ([Table 1](#T1){ref-type="table"}). The MIC ranges of tedizolid were 0.06 to 1 µg/mL for *Finegoldia magna* and ≤0.06 to 0.25 µg/mL for the other *Peptostreptococcus* spp. The MIC~90~ values for these organisms were 0.5 and 0.25 µg/mL, respectively, which were 4-8 fold lower than those of linezolid. All the *Clostridium* spp. isolates were inhibited by tedizolid at 0.5 µg/mL.

All the gram-positive isolates in patients with HAP were inhibited by ≤0.5 µg/mL tedizolid ([Table 2](#T2){ref-type="table"}). The MIC ranges of tedizolid were 0.125 to 0.5 µg/mL for MRSA and 0.25 µg/mL for MSSA. The MIC~90~ values of tedizolid were 0.25, 0.5, and 0.5 µg/mL for MSSA, MRSA, and pneumococci, respectively, which were 4- to 8-fold lower than those of linezolid.

In summary, the MIC values of tedizolid in this study were not significantly different according to type of infection. All organisms tested were susceptible to tedizolid, nevertheless the breakpoint of tedizolid is 4- or 8-fold lower than that of linezolid. Tedizolid is a potent agent with high *in vitro* activity against common aerobic and anaerobic gram-positive pathogens in SSSIs and HAP. Tedizolid may become a useful option for the treatment of SSSIs and HAP.
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###### Comparative *in vitro* activities of tedizolid and other antimicrobial agents against bacteria recovered from patients with skin and skin structure infections

![](alm-35-523-i001)

  Organism (N of isolates) and antimicrobial agents    Breakpoint (µg/mL)   MIC (µg/mL)   Susceptibility (%)                                                 
  ---------------------------------------------------- -------------------- ------------- -------------------- ---------------- -------- -------- ----- ---- -----
  Methicillin-resistant *Staphylococcus aureus* (90)                                                                                                         
   Tedizolid^\*^                                       ≤ 0.5                1             ≥2                   0.125-0.5        0.5      0.5      100   0    0
   Linezolid                                           ≤4                   \-            ≥8                   0.25-4           2        2        100   NA   0
   Erythromycin                                        ≤ 0.5                1-4           ≥8                   0.5- \> 128      \> 128   \> 128   28    0    72
   Clindamycin                                         ≤ 0.5                1-2           ≥4                   ≤ 0.06- \> 128   \> 128   \> 128   44    0    56
   Cotrimoxazole                                       ≤2                   \-            ≥4                   ≤ 0.06-32        ≤ 0.06   0.125    98    NA   2
   Gentamicin                                          ≤4                   8             ≥ 16                 0.125- \> 128    0.5      32       58    1    41
   Levofloxacin                                        ≤1                   2             ≥4                   0.25- \> 128     16       \> 128   37    0    63
   Tetracycline                                        ≤4                   8             ≥ 16                 0.5- \> 128      64       64       41    0    59
   Oxacillin                                           ≤2                   \-            ≥4                   8- \> 128        \> 128   \> 128   0     NA   100
   Vancomycin                                          ≤2                   4-8           ≥ 16                 1-4              1        2        94    6    0
  Methicillin-susceptible *S. aureus* (90)                                                                                                                   
   Tedizolid                                           ≤ 0.5                1             ≥2                   ≤ 0.06-0.5       0.25     0.5      100   0    0
   Linezolid                                           ≤4                   \-            ≥8                   0.25-2           2        2        100   NA   0
   Erythromycin                                        ≤ 0.5                1-4           ≥8                   0.25- \> 128     0.5      \> 128   74    1    24
   Clindamycin                                         ≤ 0.5                1-2           ≥4                   ≤ 0.06- \> 128   0.125    0.125    99    0    1
   Cotrimoxazole                                       ≤2                   \-            ≥4                   ≤ 0.06-0.125     ≤ 0.06   0.125    100   NA   0
   Gentamicin                                          ≤4                   8             ≥ 16                 0.125-128        0.25     32       82    1    17
   Levofloxacin                                        ≤1                   2             ≥4                   0.125-32         0.25     32       97    0    3
   Tetracycline                                        ≤4                   8             ≥ 16                 0.25-128         0.5      0.5      91    0    9
   Oxacillin                                           ≤2                   \-            ≥4                   ≤ 0.06-2         0.5      0.5      100   NA   0
   Vancomycin                                          ≤2                   4-8           ≥ 16                 1-2              1        1        100   0    0
  Coagulase-negative *Staphylococcus* (24)^†^                                                                                                                
   Tedizolid                                           NA                   NA            NA                   ≤ 0.06-0.25      0.125    0.125    NA    NA   NA
   Linezolid                                           ≤4                   \-            ≥8                   0.25-2           0.25     0.25     100   NA   0
   Erythromycin                                        ≤ 0.5                1-4           ≥8                   ≤ 0.06- \> 128   0.125    128      71    0    29
   Clindamycin                                         ≤ 0.5                1-2           ≥4                   ≤ 0.06- \> 128   ≤ 0.06   0.125    96    0    4
   Cotrimoxazole                                       ≤2                   \-            ≥4                   ≤ 0.06-4         ≤ 0.06   4        79    NA   21
   Gentamicin                                          ≤4                   8             ≥ 16                 ≤ 0.06-128       0.125    16       50    21   29
   Levofloxacin                                        ≤1                   2             ≥4                   ≤ 0.06-128       0.25     8        75    4    21
   Tetracycline                                        ≤4                   8             ≥ 16                 0.125-128        0.25     64       75    0    25
   Oxacillin                                           ≤ 0.25               \-            ≥ 0.5                0.125-128        0.5      2        38    NA   63
   Vancomycin                                          ≤4                   8-16          ≥ 32                 1-2              2        2        100   0    0
  *Streptococcus pneumoniae* (30)                                                                                                                            
   Tedizolid                                           NA                   NA            NA                   0.25-1           0.25     0.5      NA    NA   NA
   Linezolid                                           ≤2                   \-            \-                   1-2              1        2        100   NA   NA
   Penicillin G                                        ≤2                   4             ≥8                   0.06-4           4        4        27    73   0
   Cefotaxime                                          ≤1                   2             ≥4                   0.06-2           2        2        27    73   0
   Clindamycin                                         ≤ 0.25               0.5           ≥1                   0.125- \> 128    \> 128   \> 128   10    0    90
   Erythromycin                                        ≤ 0.25               0.5           ≥1                   8- \> 128        \> 128   \> 128   0     0    100
   Cotrimoxazole                                       ≤ 0.5                1-2           ≥4                   0.5- \> 128      32       64       13    0    87
   Levofloxacin                                        ≤2                   4             ≥8                   2-8              2        4        87    10   3
   Tetracycline                                        ≤1                   2             ≥4                   0.25-64          32       32       3     3    93
  *S. agalactiae* (22)                                                                                                                                       
   Tedizolid                                           ≤ 0.5                \-            \-                   0.25-0.5         0.5      0.5      100   NA   NA
   Linezolid                                           ≤2                   \-            \-                   2-4              2        2        96    NA   NA
   Penicillin G                                        ≤ 0.12               \-            \-                   0.015-0.06       0.06     0.06     100   NA   NA
   Cefotaxime                                          ≤ 0.5                \-            \-                   0.015-0.06       0.06     0.06     100   NA   NA
   Clindamycin                                         ≤ 0.25               0.5           ≥1                   0.125- \> 128    0.125    \> 128   82    0    18
   Erythromycin                                        ≤ 0.25               0.5           ≥1                   0.125- \> 128    0.25     \> 128   77    0    23
   Levofloxacin                                        ≤2                   4             ≥8                   1-64             2        64       59    9    32
   Tetracycline                                        ≤2                   4             ≥8                   0.25-32          1        32       59    0    41
  *S. pyogenes* (8)                                                                                                                                          
   Tedizolid                                           ≤ 0.5                \-            \-                   0.125-0.5        NA       NA       NA    NA   NA
   Linezolid                                           ≤2                   \-            \-                   1-2              NA       NA       NA    NA   NA
   Penicillin G                                        ≤ 0.12               \-            \-                   0.015            NA       NA       NA    NA   NA
   Cefotaxime                                          ≤ 0.5                \-            \-                   0.015-0.06       NA       NA       NA    NA   NA
   Clindamycin                                         ≤ 0.25               0.5           ≥1                   0.125- \> 128    NA       NA       NA    NA   NA
   Erythromycin                                        ≤ 0.25               0.5           ≥1                   0.25-32          NA       NA       NA    NA   NA
   Levofloxacin                                        ≤2                   4             ≥8                   0.5-8            NA       NA       NA    NA   NA
   Tetracycline                                        ≤2                   4             ≥8                   0.25-8           NA       NA       NA    NA   NA
  *Enterococcus faecalis* (14)                                                                                                                               
   Tedizolid                                           ≤ 0.5                \-            \-                   0.25-0.5         0.5      0.5      100   NA   NA
   Linezolid                                           ≤2                   4             ≥8                   1-2              2        2        100   0    0
   Ampicillin                                          ≤8                   \-            ≥ 16                 0.5-4            1        4        100   NA   0
   Erythromycin                                        ≤ 0.5                1-4           ≥8                   0.5- \> 128      \> 128   \> 128   0     36   64
   Levofloxacin                                        ≤2                   4             ≥8                   1- \> 128        1        128      64    0    36
   Tetracycline                                        ≤4                   8             ≥ 16                 0.5- \> 128      64       128      14    0    86
   Teicoplanin                                         ≤8                   16            ≥ 32                 ≤ 0.06-1         0.5      1        100   0    0
   Vancomycin                                          ≤4                   8-16          ≥ 32                 0.5-4            1        2        100   0    0
  *E. faecium* (16)                                                                                                                                          
   Tedizolid                                           NA                   NA            NA                   0.25-0.5         0.25     0.25     NA    NA   NA
   Linezolid                                           ≤2                   4             ≥8                   0.5-2            2        2        100   0    0
   Ampicillin                                          ≤8                   \-            ≥ 16                 16- \> 128       64       128      0     NA   100
   Erythromycin                                        ≤ 0.5                1-4           ≥8                   ≤ 0.06- \> 128   \> 128   \> 128   6     0    94
   Levofloxacin                                        ≤2                   4             ≥8                   32-128           128      128      0     0    100
   Tetracycline                                        ≤4                   8             ≥ 16                 0.25-128         0.5      128      56    0    44
   Vancomycin                                          ≤4                   8-16          ≥ 32                 1- \> 128        1        \> 128   56    0    44
   Teicoplanin                                         ≤8                   16            ≥ 32                 0.25-128         1        32       56    19   25
  Viridans group *Streptococcus* spp. (10)^‡^                                                                                                                
   Tedizolid                                           NA                   NA            NA                   0.25-0.5         0.25     0.25     NA    NA   NA
   Linezolid                                           ≤2                   \-            \-                   1-2              1        2        100   NA   NA
   Penicillin G                                        ≤ 0.12               0.25-2        ≥4                   0.03-2           0.06     0.5      70    10   0
   Cefotaxime                                          ≤1                   2             ≥4                   0.06-2           0.25     1        90    10   0
   Clindamycin                                         ≤ 0.25               0.5           ≥1                   ≤ 0.06- \> 128   0.125    \> 128   60    0    40
   Erythromycin                                        ≤ 0.25               0.5           ≥1                   ≤ 0.06- \> 128   0.125    128      50    10   40
   Levofloxacin                                        ≤2                   4             ≥8                   0.5-2            1        2        100   0    0
   Tetracycline                                        ≤2                   4             ≥8                   0.25-64          16       64       40    0    60
  *Finegoldia magna* (21)                                                                                                                                    
   Tedizolid                                           NA                   NA            NA                   0.06-1           0.25     0.5      NA    NA   NA
   Linezolid                                           NA                   NA            NA                   0.5-2            2        2        NA    NA   NA
   Piperacillin                                        ≤ 32                 64            ≥ 128                ≤ 0.06-0.25      0.125    0.25     100   0    0
   Pip/tazobactam                                      ≤ 32                 64            ≥ 128                ≤ 0.06-0.25      ≤ 0.06   0.125    100   0    0
   Cefoxitin                                           ≤ 16                 32            ≥ 64                 0.125-2          1        1        100   0    0
   Cefotetan                                           ≤ 16                 32            ≥ 64                 0.25-2           1        2        100   0    0
   Imipenem                                            ≤4                   8             ≥ 16                 ≤ 0.06-0.125     ≤ 0.06   0.125    100   0    0
   Clindamycin                                         ≤2                   4             ≥8                   ≤ 0.06- \> 128   2        \> 128   55    9    36
   Metronidazole                                       ≤8                   16            ≥ 32                 0.25-4           1        2        100   0    0
   Vancomycin                                          NA                   NA            NA                   0.25-1           0.25     0.5      NA    NA   NA
  *Peptostreptococcus* spp. (27)^§^                                                                                                                          
   Tedizolid                                           NA                   NA            NA                   ≤ 0.06-0.25      0.125    0.25     NA    NA   NA
   Linezolid                                           NA                   NA            NA                   0.5-2            1        2        NA    NA   NA
   Piperacillin                                        ≤ 32                 64            ≥ 128                ≤ 0.06-1         ≤ 0.06   1        100   0    0
   Pip/tazobactam                                      ≤ 32                 64            ≥ 128                ≤ 0.06-1         ≤ 0.06   0.25     100   0    0
   Cefoxitin                                           ≤ 16                 32            ≥ 64                 ≤ 0.06-8         0.5      4        100   0    0
   Cefotetan                                           ≤ 16                 32            ≥ 64                 0.125-8          0.5      2        100   0    0
   Imipenem                                            ≤4                   8             ≥ 16                 ≤ 0.06-0.5       ≤ 0.06   0.125    100   0    0
   Clindamycin                                         ≤2                   4             ≥8                   ≤ 0.06-128       0.25     128      74    4    22
   Metronidazole                                       ≤8                   16            ≥ 32                 0.5-2            1        2        100   0    0
   Vancomycin                                          NA                   NA            NA                   0.125-1          0.25     1        NA    NA   NA
  *Clostridium* spp. (4)^∥^                                                                                                                                  
   Tedizolid                                           NA                   NA            NA                   0.25-0.5         NA       NA       NA    NA   NA
   Linezolid                                           NA                   NA            NA                   2-4              NA       NA       NA    NA   NA
   Piperacillin                                        ≤ 32                 64            ≥ 128                0.25-2           NA       NA       NA    NA   NA
   Pip/tazobactam                                      ≤ 32                 64            ≥ 128                0.125-2          NA       NA       NA    NA   NA
   Cefoxitin                                           ≤ 16                 32            ≥ 64                 4-32             NA       NA       NA    NA   NA
   Cefotetan                                           ≤ 16                 32            ≥ 64                 0.25-2           NA       NA       NA    NA   NA
   Imipenem                                            ≤4                   8             ≥ 16                 0.25-2           NA       NA       NA    NA   NA
   Clindamycin                                         ≤2                   4             ≥8                   0.125- \> 128    NA       NA       NA    NA   NA
   Metronidazole                                       ≤8                   16            ≥ 32                 0.5-8            NA       NA       NA    NA   NA
   Vancomycin                                          NA                   NA            NA                   0.5-4            NA       NA       NA    NA   NA

^\*^FDA breakpoints were used for tedizolid; ^†^*Staphylococcus epidermidis* (N=22), *S. caprae* (N=1), *S. warneri* (N=1); ^‡^*Streptococcus mitis* (N=6), *S. anginosus* (N=2), *S. constellatus* (N=2); ^§^*P. asaccharolyticus* (N=11), *P. micros* (N=7), *Anaerococcus prevotii* (N=8), *P. anaerobius* (N=1); ^∥^*C. perfringens* (N=2), *C. ramosum* (N=2).

Abbreviations: MIC, minimum inhibitory concentration; S, susceptible; I, intermediate; R, resistant; NA, not available/applicable; Pip/tazobactam, piperacillin/tazobactam.

###### Comparative *in vitro* activities of tedizolid and other antimicrobial agents against bacteria recovered from patients with hospital-acquired pneumonia
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  Organism (N of isolates) and antimicrobial agents    Breakpoint (µg/mL)   MIC (µg/mL)   Susceptibility (%)                                                
  ---------------------------------------------------- -------------------- ------------- -------------------- --------------- -------- -------- ----- ---- -----
  Methicillin-resistant *Staphylococcus aureus* (61)                                                                                                        
   Tedizolid^\*^                                       ≤0.5                 1             ≥2                   0.125-0.5       0.25     0.5      100   0    0
   Linezolid                                           ≤4                   \-            ≥8                   1-2             2        2        100   NA   0
   Erythromycin                                        ≤0.5                 1-4           ≥8                   0.25- \> 128    \> 128   \> 128   10    0    90
   Clindamycin                                         ≤0.5                 1-2           ≥4                   ≤0.06- \> 128   \> 128   \> 128   23    0    77
   Cotrimoxazole                                       ≤2                   \-            ≥4                   ≤0.06-4         ≤0.06    0.125    98    NA   2
   Gentamicin                                          ≤4                   8             ≥16                  0.125-128       32       64       38    0    62
   Levofloxacin                                        ≤1                   2             ≥4                   0.25- \> 128    32       32       16    0    84
   Tetracycline                                        ≤4                   8             ≥16                  0.25-128        128      128      18    0    82
   Oxacillin                                           ≤2                   \-            ≥4                   32- \> 128      \> 128   \> 128   0     NA   100
   Vancomycin                                          ≤2                   4-8           ≥16                  0.5-2           1        2        100   0    0
  Methicillin-susceptible *S. aureus* (28)                                                                                                                  
   Tedizolid                                           ≤0.5                 1             ≥2                   0.25-0.25       0.25     0.25     100   0    0
   Linezolid                                           ≤4                   \-            ≥8                   1-2             2        2        100   NA   0
   Erythromycin                                        ≤0.5                 1-4           ≥8                   0.25- \> 128    0.25     0.25     93    4    4
   Clindamycin                                         ≤0.5                 1-2           ≥4                   ≤0.06-64        ≤0.06    ≤0.06    93    4    4
   Cotrimoxazole                                       ≤2                   \-            ≥4                   ≤0.06-0.25      ≤0.06    ≤0.06    100   NA   0
   Gentamicin                                          ≤4                   8             ≥16                  0.125-16        0.25     0.25     96    0    4
   Levofloxacin                                        ≤1                   2             ≥4                   0.125-8         0.25     1        93    0    7
   Tetracycline                                        ≤4                   8             ≥16                  0.25-0.25       0.25     0.25     100   0    0
   Oxacillin                                           ≤2                   \-            ≥4                   0.125-0.5       0.25     0.5      100   NA   0
   Vancomycin                                          ≤2                   4-8           ≥16                  1-2             1        1        100   0    0
  *S. epidermidis* (8)                                                                                                                                      
   Tedizolid                                           NA                   NA            NA                   ≤0.06           NA       NA       NA    NA   NA
   Linezolid                                           ≤4                   \-            ≥8                   0.25            NA       NA       NA    NA   NA
   Erythromycin                                        ≤0.5                 1-4           ≥8                   ≤0.06-128       NA       NA       NA    NA   NA
   Clindamycin                                         ≤0.5                 1-2           ≥4                   ≤0.06- \> 128   NA       NA       NA    NA   NA
   Cotrimoxazole                                       ≤2                   \-            ≥4                   ≤0.06-4         NA       NA       NA    NA   NA
   Gentamicin                                          ≤4                   8             ≥16                  ≤0.06-128       NA       NA       NA    NA   NA
   Levofloxacin                                        ≤1                   2             ≥4                   4-128           NA       NA       NA    NA   NA
   Tetracycline                                        ≤4                   8             ≥16                  0.125-32        NA       NA       NA    NA   NA
   Oxacillin                                           ≤0.25                \-            ≥0.5                 0.5-32          NA       NA       NA    NA   NA
   Vancomycin                                          ≤4                   8-16          ≥32                  1-2             NA       NA       NA    NA   NA
  *Streptococcus pneumoniae* (47)                                                                                                                           
   Tedizolid                                           NA                   NA            NA                   0.25-0.5        0.25     0.5      NA    NA   NA
   Linezolid                                           ≤2                   \-            \-                   1-2             1        2        100   NA   NA
   Penicillin G                                        ≤2                   4             ≥8                   0.015-8         2        8        49    28   23
   Cefotaxime                                          ≤1                   2             ≥4                   0.015-32        1        32       55    26   19
   Clindamycin                                         ≤0.25                0.5           ≥1                   0.125- \> 128   \> 128   \> 128   15    0    85
   Erythromycin                                        ≤0.25                0.5           ≥1                   0.25- \> 128    \> 128   \> 128   6     0    94
   Cotrimoxazole                                       ≤0.5                 1-2           ≥4                   1-32            8        32       23    15   62
   Levofloxacin                                        ≤2                   4             ≥8                   2-128           2        32       72    2    26
   Tetracycline                                        ≤1                   2             ≥4                   0.25-128        32       64       13    0    87

^\*^FDA breakpoints were used for tedizolid.

Abbreviations: MIC, minimum inhibitory concentration; S, susceptible; I, intermediate; R, resistant; NA, not available/applicable; Pip/tazobactam, piperacillin/tazobactam.
